Skip to main content

Table 4 Cure rates following treatment

From: Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

   

p-valueb

Physician-treated

Relief

84.4% (141)a

p < 0.0001

No relief

15.6% (26)

Self-medicated

Relief

57.4% (74)

NSc

No relief

42.6% (55)

Post-treatment outcome

Cure

46.8% (94)

NSc

Recurrence

53.2% (107)

RVVCd maintenance regimens

Constant/as needed antifungal medication – relief

71.1% (74)

p < 0.0001

Constant antifungal medication – no relief

19.2% (20)

Avoiding known risk factors without medication

9.6% (10)

  1. aValues in parentheses indicate the number of respondents who selected each response choice
  2. bData were analyzed by Fisher’s exact test for binomial distribution
  3. cNS, not significant
  4. dRVVC, recurrent vulvovaginal candidiasis defined as 4 or more acute episodes in a 12-month period